USPTO 2015–2025 USPTO PatentsView US Corporation

Codexis, Inc.

USPTO PatentsView assignee record - 350 granted patents across 26 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

RSS updates for this company

The verdict

According to USPTO PatentsView, Codexis ranks #1,212 of 49,997 tracked US assignees by granted-patent volume, with 350 patents across 26 technology areas.

#1,212
of 49,997 US assignees by volume
Top 11%
by Innovation Score (52.1/100)
15.3
avg claims per patent
-12%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1212 · US Corporation #1,212 · 350 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-MID 350 grants
  • TOP-DECILE #1,212/49,997
  • PHOTO-FINISH Clarion
  • CPC-FOCUS C12N · 26 areas
  • INNOV-PAR 52.1/100
  • CLAIMS-RICH 15.3 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DOWN -12% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Clarion Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Codexis

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Codexis's Innovation Score is 52.1/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Codexis's grants concentrate

Codexis, Inc. is a focused PatentsView assignee: 26 CPC subclasses with 98.9% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2020 (40 grants) versus a trough of 21 in 2023. By volume, Codexis sits between Lumentum Operations LLC and JX Nippon Mining & Metals Corporation.

Codexis's three-year grant acceleration

From 2019–2021 to 2022–2024, Codexis, Inc. moved from 103 to 72 grants (0.70x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,156. See the growth leaderboard.

Who files at Codexis's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Codexis holds 350 patents at rank #1,212, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Codexis

By rank, the assignees closest to #1,212 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Codexis's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Codexis, neither rank-band nor same-CPC leaders (those blocks stay above).

Codexis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

52 Top 11% higher than 89% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

202530354045 20152016201720182019202020212022202320242025 34
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Codexis, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 38 10.9%
2016 36 10.3%
2017 37 10.6%
2018 30 8.6%
2019 27 7.7%
2020 40 11.4%
2021 36 10.3%
2022 26 7.4%
2023 21 6.0%
2024 25 7.1%
2025partial year 34 9.7%

Which technologies does Codexis, Inc. patent most?

Top 15 of 26 technology areas

Where it ranks

Overall rank by patents

#1,212

of 49,997 tracked assignees

Innovation Score

52.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Codexis, Inc.'s patent record in context - here's where to go next.

  • Codexis, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 98.9% of its portfolio - see every assignee active in that class. Explore C12N
  • Ranked #1,212 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Codexis, Inc. against Lumentum Operations LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 52.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.